
WuXi STA
Changzhou, China sta.wuxiapptec.com From their website, Nov 2026
- GMP
Work here? Claim this listing
About
WuXi STA provides contract development and manufacturing services for small-molecule and synthetic-molecule pharmaceuticals. It serves clients globally from facilities across Asia, North America, and Europe, supporting projects from preclinical through commercial stages.
Services
API process development
Develops synthetic routes and process R&D for starting materials, intermediates, and active pharmaceutical ingredients from preclinical to commercial launch.
API manufacturing
Manufactures small-molecule intermediates, building blocks, and drug substance from gram to metric-ton scale.
High potency API
Provides process R&D and manufacturing for high-potency APIs, including facilities handling HP compounds with an OEL of 10 ng/m3.
Flow chemistry
Offers process development, non-GMP, and GMP production services using continuous manufacturing flow chemistry.
Biocatalysis
Uses enzyme-based biocatalysis for stereoselective biotransformations and enantiomer resolutions.
Drug product oral solid development
Supports pre-formulation, formulation development, and manufacturing for oral solid dosage forms.
Pre-formulation
Studies physicochemical properties to support selection of developable molecules at the preclinical stage.
Formulation development
Develops oral solid formulations from preclinical to commercial manufacturing.
19 more services
- Oral solid state development
- Drug product parenteral development
- Parenteral manufacturing
- Clinical supply service
- Analytical development and quality control
- Regulatory CMC dossier preparation
- Spray dried dispersion
- Process Development
- Manufacturing
- Preparative HPLC, SFC, and SMB
- Crystallization and Particle Engineering
- Drug Product Development
- Parenteral Development
- Lipid Nanoparticle Platform
- Hot Melt Extrusion
- Lipid Formulation
- Nano Suspension
- Reference Standard Characterization and Qualification
- Regulatory Dossier Preparation
- Lead time
- 6-8 weeks to prepare IND submission package for US FDA
- What to send
- Work Email
- Company / Institution
- Country / Region
Capabilities
As they state on their website or in their listing.
- Processes
- Small molecule
- Peptide
- Oligonucleotide
- LNP / formulation
- LNP
- Process development
3 more
- HPLC
- Analytical development
- Stability studies
- Capacity
- Few grams to metric ton scale
- OEL of 10 ng/m3
- 5 production lines
- Total reactor volume exceeds 4,000 m3
- 6 sites in Asia and North America
- 3,600+ process chemists and analytical scientists
7 more
- 1,500+ formulators & analytical scientists
- 3,500+ analytical scientists
- OEL ≥10 ng/m³
- 2024: 1,000+ preclinical-phase III molecules supported
- 50+ late-phase NCEs validated
- 10+ commercial products supported
- 740+ CMC submission packages written during 2019-2024
- Scales
- Gram · Kilogram · Ton
- Data supplied
- HPLC
Equipment
- Prep-HPLC
- SFC
- SMB
- Spray dryers
Certifications
As the company states them, with the certificate or registry record where there is one.
GMPSelf-reported
Details
- Type
- CRDMO
- Team
- 3,600+ process chemists and analytical scientists; 1,500+ formulators & analytical scientists; 3,500+ analytical scientists
- Office
- Manufacturing 20+ years' experience Over 20 years of experience in API manuf
- Sites
- Shanghai Waigaoqiao, China
- Shanghai, China
- Wuxi City, China
- Taixing, China
- Jinshan, China
- Tuas, Singapore
4 more
- Middletown, Delaware, USA
- San Diego, California, USA
- Couvet, Neuchâtel, Switzerland
- Shanghai Jinshan, China
- Serves
- Globally, Asia, North America, Europe, 105 countries, worldwide